FRANCISCO DIAZ: Open Payments
NPI 1417968215 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 12 payments from 5 companies in 2025. Trend: 2023 $1,040 · 2024 $711 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $216 |
| Insulet Corporation | 1 | $175 |
| Dexcom, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $103 |
| GlaxoSmithKline, LLC. | 4 | $77 |
Products named: Omnipod, Dexcom G6 Transmitter, MOUNJARO, Ozempic, TRELEGY ELLIPTA, AREXVY, NUCALA.
Industry payments across NY — which companies pay providers there.
